Literature DB >> 18594937

Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP.

Krassimira Ivanova1, Britta Lambers, Rene van den Wijngaard, I Caroline Le Poole, Olga Grigorieva, Rupert Gerzer, Pranab K Das.   

Abstract

Nitric oxide (NO) is an important mediator in many (patho)physiological processes including inflammation and skin cancer. A key transducer in NO signaling is the soluble guanylyl cyclase (sGC) that catalyzes the formation of guanosine 3',5'-cyclic monophosphate (cGMP). The basic mechanism of NO-cGMP signaling in melanocytic cells is, however, not well elucidated. A setback for such studies is the limited availability of patient-derived melanocytes. Here, we report that immortalized human normal and vitiliginous cell lines generated via cell transfection with human papilloma virus 16 genes E6 and E7 express NO synthase and guanylyl cyclase isoforms and the multidrug resistance-associated proteins 4 and 5 as selective cGMP exporters. Donors of NO (e.g., the NONOate (Z)-1-[N-(3-ammoniopropyl)-N-(n-propyl)amino]diazen-1-ium-1,2-diolate (PAPA-NO) and reactive nitrogen oxygen species (RNOS) like 3-morpholino-sydnonimine (SIN-1) as a donor of peroxynitrite as well as YC-1 as a NO-independent sGC stimulator increased intracellular cGMP levels in immortalized melanocytes (up to eightfold over controls), indicating the expression of functional sGC in these cells. PAPA-NO and SIN-1 also reduced the attachment of immortalized melanocytes to extracellular matrix (ECM) components like fibronectin which was dependent on cellular melanin content and cGMP. Such effects on melanoma cells were positively related to metastatic potential and were cGMP independent. Intriguingly, nonpigmented metastatic melanoma cells were more sensitive to exogenous sources of RNOS than of NO. Thus, immortalized melanocytes can be used as a tool for further research on differences in cell signaling between the different melanocytic lineages in particular towards impairment of cell-ECM adhesion by NO or RNOS, which may be important in metastasis and vitiligo pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594937     DOI: 10.1007/s11626-008-9113-1

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  52 in total

Review 1.  The physical and chemical properties of eumelanin.

Authors:  Paul Meredith; Tadeusz Sarna
Journal:  Pigment Cell Res       Date:  2006-12

2.  Effects of nitric oxide-containing compounds on increases in cytosolic ionized Ca2+ and on aggregation of human platelets.

Authors:  K Ivanova; M Schaefer; C Drummer; R Gerzer
Journal:  Eur J Pharmacol       Date:  1993-01-04       Impact factor: 4.432

3.  "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

Authors:  L K Keefer; R W Nims; K M Davies; D A Wink
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.

Authors:  Masahide Ikeguchi; Tsuyoshi Ueta; Yoshiaki Yamane; Yasuaki Hirooka; Nobuaki Kaibara
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

5.  Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

Authors:  Gergely Szakács; Jean-Philippe Annereau; Samir Lababidi; Uma Shankavaram; Angela Arciello; Kimberly J Bussey; William Reinhold; Yanping Guo; Gary D Kruh; Mark Reimers; John N Weinstein; Michael M Gottesman
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

6.  Stimulation of cyclic GMP efflux in human melanocytes by hypergravity generated by centrifugal acceleration.

Authors:  Krassimira Ivanova; Nahid Hamidi Zadeh; Ingrid Block; Pranab K Das; Rupert Gerzer
Journal:  Pigment Cell Res       Date:  2004-10

Review 7.  Nitric oxide function in the skin.

Authors:  M-M Cals-Grierson; A D Ormerod
Journal:  Nitric Oxide       Date:  2004-06       Impact factor: 4.427

8.  Oxidative stress in malignant melanoma and non-melanoma skin cancer.

Authors:  C S Sander; F Hamm; P Elsner; J J Thiele
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

9.  Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production.

Authors:  Mark Gilchrist; Scott D McCauley; A Dean Befus
Journal:  Blood       Date:  2004-03-25       Impact factor: 22.113

10.  On the mechanism of NO release from sydnonimines.

Authors:  M Feelisch; J Ostrowski; E Noack
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

View more
  3 in total

1.  Involvement of VILIP-1 (visinin-like protein) and opposite roles of cyclic AMP and GMP signaling in in vitro cell migration of murine skin squamous cell carcinoma.

Authors:  Katharina Schönrath; Wensheng Pan; Andres J Klein-Szanto; Karl-Heinz Braunewell
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

2.  Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP.

Authors:  Stavroula Baritaki; Sara Huerta-Yepez; Anna Sahakyan; Iordanis Karagiannides; Kyriaki Bakirtzi; Ali Jazirehi; Benjamin Bonavida
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

Review 3.  Guanylyl Cyclase-cGMP Signaling Pathway in Melanocytes: Differential Effects of Altered Gravity in Non-Metastatic and Metastatic Cells.

Authors:  Krassimira Ivanova; Ruth Hemmersbach
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.